Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010;17(1):25-30.
doi: 10.1258/jms.2009.009094.

Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England

Stephen W Duffy  1 , Laszlo Tabar, Anne Helene Olsen, Bedrich Vitak, Prue C Allgood, Tony H H Chen, Amy M F Yen, Robert A Smith
Affiliations

Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England

Stephen W Duffy et al. J Med Screen. 2010.

Erratum in

  • J Med Screen. 2010 Jun;17(2):106

Abstract

Objectives: To estimate the absolute numbers of breast cancer deaths prevented and the absolute numbers of tumours overdiagnosed in mammographic screening for breast cancer at ages 50-69 years.

Setting: The Swedish Two-County randomized trial of mammographic screening for breast cancer, and the UK Breast Screening Programme in England, ages 50-69 years.

Methods: We estimated the absolute numbers of deaths avoided and additional cases diagnosed in the study group (active study population) of the Swedish Two-County Trial, by comparison with the control group (passive study population). We estimated the same quantities for the mortality and incidence rates in England (1974-2004 and 1974-2003, respectively). We used Poisson regression for statistical inference.

Results: A substantial and significant reduction in breast cancer mortality was associated with screening in both the Two-County Trial (P < 0.001) and the screening programme in England (P < 0.001). The absolute benefits were estimated as 8.8 and 5.7 breast cancer deaths prevented per 1000 women screened for 20 years starting at age 50 from the Two-County Trial and screening programme in England, respectively. The corresponding estimated numbers of cases overdiagnosed per 1000 women screened for 20 years were, respectively, 4.3 and 2.3 per 1000.

Conclusions: The benefit of mammographic screening in terms of lives saved is greater in absolute terms than the harm in terms of overdiagnosis. Between 2 and 2.5 lives are saved for every overdiagnosed case.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Breast cancer mortality in England 1974–2004
Figure 2
Figure 2
Breast cancer incidence in England 1974–2003
See this image and copyright information in PMC

Comment in

References

    1. Tabar L, Vitak B, Yen MFA, Chen HHT, Smith RA, Duffy SW Number needed to screen-lives saved over 20 years of follow-up in mammographic screening. J Med Screen 2004;11:126–9 - PubMed
    1. Swedish Organised Service Screening Evaluation Group Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data. Cancer Epidemiol Biomarkers Prev 2006;15:45–51 - PubMed
    1. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. Br Med J 2006;332:689–92 - PMC - PubMed
    1. Zahl PH, Strand BH, Maehlen J Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 2004;328:921–4 - PMC - PubMed
    1. Duffy SW, Lynge E, Jonsson H, Ayyaz S, Olsen AH Complexities in the estimation of overdiagnosis in breast cancer screening. Br J Cancer 2008;99:1176–8 - PMC - PubMed